Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression: Role of Inflammation and Kynurenine Pathway Biomarkers.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Celecoxib (Primary) ; Escitalopram (Primary)
- Indications Bipolar depression
- Focus Biomarker; Therapeutic Use
- 04 Mar 2019 Biomarkers information updated
- 29 Oct 2012 Planned End Date changed from 1 Sep 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 28 Nov 2011 New trial record